title: Targeting specific traditional risk factors to improve cardiovascular outcomes: Sound or flawed?
authors.affiliation: Department of Internal Medicine/Cardiology, Wake Forest University, School of Medicine, Winston-Salem, NC, United States. jyeboah@wakehealth.edu
authors.forename: Joseph
authors.initials: J
authors.lastname: Yeboah
mesh_terms: D000069059:Atorvastatin; D003324:Coronary Artery Disease / Q000188:drug therapy*; D004730:Endothelium, Vascular / Q000187:drug effects*; D005260:Female; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D009525:Niacin / Q000008:administration & dosage*; D011758:Pyrroles / Q000627:therapeutic use*
chemical_list: D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D009525:Niacin; D000069059:Atorvastatin